Cargando…

Pharmacogenetics to Avoid Adverse Drug Reactions

Detalles Bibliográficos
Autor principal:	López-Fernández, Luis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879652/ https://www.ncbi.nlm.nih.gov/pubmed/35207648 http://dx.doi.org/10.3390/jpm12020159

Ejemplares similares

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Precision dosing to avoid adverse drug reactions
por: Polasek, Thomas M., et al.
Publicado: (2019)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Pharmacogenetics for severe adverse drug reactions induced by molecular‐targeted therapy
por: Udagawa, Chihiro, et al.
Publicado: (2020)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool
por: Bracken, Louise E., et al.
Publicado: (2017)

Protecting Patients from Adverse Drug Events: Propoxyphene, PIMs, and Drugs to Avoid in Older Adults
por: Curtiss, Frederic R., et al.
Publicado: (2011)

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions
por: Böhm, Ruwen, et al.
Publicado: (2016)

“Pharmacogenetics of Cancer” - Cancer Drug Resistance special issue
por: Mini, Enrico, et al.
Publicado: (2020)

Publication bias in pharmacogenetics of adverse reaction to antiseizure drugs: An umbrella review and a meta-epidemiological study
por: Bally, S., et al.
Publicado: (2022)

Insight into Risk Factors, Pharmacogenetics/Genomics, and Management of Adverse Drug Reactions in Elderly: A Narrative Review
por: Bellanca, Carlo Maria, et al.
Publicado: (2023)

Adverse drug reactions and ivermectin in COVID-19
por: Montastruc, Jean-Louis
Publicado: (2022)

Adverse Reactions to Anticancer Drugs in the Oral Cavity
por: Di Fede, Olga, et al.
Publicado: (2018)

Monitoring adverse drug reactions in the community settings
por: Ab Rahman, Ab Fatah
Publicado: (2019)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

Severe Adverse Drug Reactions in Korean Elderly Patients
por: Lee, Jungun
Publicado: (2022)

An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

Association Studies in Clinical Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Sutton's law and severe cutaneous adverse drug reactions: Is the money in the blister?
por: Chow, Timothy G., et al.
Publicado: (2021)

Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions
por: Chen, Zhibin, et al.
Publicado: (2014)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Use of a multi-gene pharmacogenetic panel reduces adverse drug effects
por: Cavallari, Larisa H., et al.
Publicado: (2023)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
por: Jang, Gwang Cheon
Publicado: (2019)

Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation
por: Turongkaravee, Saowalak, et al.
Publicado: (2021)

Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study
por: Gupta, Saurabh, et al.
Publicado: (2023)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin‐Induced Cutaneous Adverse Drug Reactions
por: Fohner, Alison E., et al.
Publicado: (2020)

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics
por: López-Fernández, Luis A.
Publicado: (2018)

Pharmacogenetics of analgesic drugs
por: Cregg, Roman, et al.
Publicado: (2013)

Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002)

Pharmacogenetic And Tumour Drugs
por: Topic, Elizabeta
Publicado: (2005)

Mining drug–target and drug–adverse drug reaction databases to identify target–adverse drug reaction relationships
por: Galletti, Cristiano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tm3mf72vu1rhlt2d757cagu16